| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 1.508 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 1.508 | 0 | 0 | 0 | 0 | 6.364 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.930 | 2.787 | 845 | 0 | 0 | 0 | 6.364 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -2.930 | -1.278 | -845 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -2.930 | -1.278 | -845 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sd Biostase - Laboratoires Marins S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.650 | 2.089 | 1.429 | 1.402 | 1.375 | 1.349 | 1.319 | 1.323 | 1.319 | 0 |
| Inventories | 785 | 777 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 759 | 1.169 | 1.166 | 1.144 | 1.122 | 1.101 | 1.076 | 1.080 | 1.077 | 0 |
| Cash | 107 | 143 | 263 | 258 | 253 | 248 | 243 | 244 | 243 | 0 |
| Shareholders Funds | -6.854 | -8.062 | -8.770 | -8.609 | -8.442 | -8.282 | -8.099 | -8.124 | -8.099 | 0 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 8.504 | 10.151 | 10.199 | 10.012 | 9.818 | 9.632 | 9.418 | 9.447 | 9.419 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8292 - 8292" | |||||||||
| CAEN Financial Year |
8292
|
|||||||||
Comments - Sd Biostase - Laboratoires Marins S.r.l.